A potent, cell-premeable, reversible, substrate competitive, and selective inhibitor of HER-2 (neu/erbB-2, IC50 = 0.35 µM) relative to HER-1 (IC50 = 19 µM) autophosphorylation. The inhibition is competitive with respect to ATP binding. Enhances the chemosensitivity in non-small cell lung cancer (NSCLC) cell lines expressing high levels of p185neu.
生化/生理作用
Cell permeable: yes
Primary Target HER2
Product does not compete with ATP.
Reversible: yes
Target IC50: 0.35 µM against HER2
準備報告
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2-3 months at -20°C.
其他說明
Ashton, J.M., et al. 2012. Cell Stem Cell11, 359. Tsai, C.M., et al. 1996. Cancer Res.56, 1068. Levitzki, A., and Gazit, A. 1995. Science267, 1782. Osherov, N., et al. 1993. J. Biol. Chem. 268, 11134.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany